Hosseini-Moghaddam SM, Iran-Pour E, Rotstein C, Husain S, Lilly L, Renner E, Mazzulli T (2012) Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up
In terms of long-term use, both Semaglutide and Tirzepatide have been FDA-approved for chronic weight management: Semaglutide under the brand Wegovy and Tirzepatide under the brand Zepbound
As the review concludes, The effect of GLP-1 analogues on the gut microbiota may have a positive impact on the long-term treatment of diabetes. However, further work is needed
Tirzepatide sits in the middle of the GLP-1 research class
The protocol at Perfect B for post-surgical patients is individualized to the surgery type, healing phase, and any concurrent physical therapy, because the timing and dosing need to complement the staged healing process rather than work around it
Week 1 through 4 begins at 0.25mg weekly